Department of Medicine, Nazarbayev University, Astana, Kazakhstan.
Department of Medicine, Nazarbayev University, Astana, Kazakhstan
BMJ Open. 2023 Oct 11;13(10):e074208. doi: 10.1136/bmjopen-2023-074208.
This study aims to estimate tuberculosis (TB) incidence, mortality rates and survival HRs in Kazakhstan, using large-scale administrative health data records during 2014-2019.
A retrospective cohort study.
Data for patients with TB in Kazakhstan during 2014-2019, reported in the Unified National Electronic Healthcare System.
Patients with TB in Kazakhstan (ICD-10 (The International Classification of Diseases, 10th revision) codes: A15-A19).
Demographic factors, diagnoses and comorbidities were analysed using descriptive, bivariate and multivariable statistical analyses. TB incidence and mortality rates were calculated, and Cox regression and Kaplan-Meier survival analysis were performed to assess risk factors for survival rates.
Of the 149 122 patients with TB, 91 437 (61%) were males, and 139 931 (94%) had respiratory TB. From 2014 to 2019, TB incidence declined from 227 to 15.2 per 100 000 individuals, while all-cause mortality increased from 8.4 to 15.2 per 100 000. Age-specific TB incidence was lowest for 0-10 years of age and highest for 20 years of age. Being older, man, urban residence versus rural, retired versus employed, having HIV and having diabetes versus no comorbidities were associated with lower survival rates.
To date, this is the largest TB published study for Kazakhstan, characterising TB incidence and mortality trends by demographic factors, and risk factors for survival rates. The findings highlight the need for targeted interventions to address the growing burden of TB, particularly among older adults, men, urban residents and those with HIV and diabetes. The study underscores the importance of using administrative health data to inform policy and health system responses to TB in Kazakhstan.
本研究旨在利用 2014-2019 年大规模行政医疗数据记录,估算哈萨克斯坦的结核病(TB)发病率、死亡率和生存率。
回顾性队列研究。
报告于哈萨克斯坦统一国家电子医疗保健系统的 2014-2019 年结核病患者数据。
哈萨克斯坦的结核病患者(国际疾病分类第 10 版代码:A15-A19)。
使用描述性、双变量和多变量统计分析方法分析人口统计学因素、诊断和合并症。计算 TB 发病率和死亡率,并进行 Cox 回归和 Kaplan-Meier 生存分析,以评估生存率的危险因素。
在 149122 例结核病患者中,91437 例(61%)为男性,139931 例(94%)患有呼吸道结核病。2014 年至 2019 年,TB 发病率从 227 例降至 15.2 例/10 万人,全因死亡率从 8.4 例升至 15.2 例/10 万人。特定年龄的 TB 发病率在 0-10 岁年龄组最低,20 岁年龄组最高。年龄较大、男性、城市居住而非农村、退休而非就业、患有 HIV 和患有糖尿病而非无合并症与较低的生存率相关。
迄今为止,这是哈萨克斯坦最大的结核病发表研究,描述了 TB 发病率和死亡率趋势的人口统计学因素,以及生存率的危险因素。研究结果强调了需要采取有针对性的干预措施来应对结核病日益加重的负担,特别是在老年人、男性、城市居民以及 HIV 和糖尿病患者中。该研究强调了使用行政医疗数据为哈萨克斯坦的结核病提供政策和卫生系统应对措施的重要性。